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Highlights 
 In vitro exposure to low-doses HQ can alter the epigenetic signature of HL60 cells 
 In vitro treatment with low-doses HQ determine instauration of histone bivalent mark  
 Epigenetic modifications after in vitro treatment with HQ are reversible 
 In vitro low-dose HQ determine no significant variation in DNA methylation on LINE-1 
 
 
Abstract 
Benzene is extensively used in industry despite its leukemogenic activity, representing a significant 
occupational hazard. We investigated if long-term treatment with low-doses hydroquinone (HQ), a 
benzene metabolite, might be sufficient to alter in vitro the epigenetic signature underlining LINE-1 
sequences, a poorly explored step in health risks associated with benzene exposure. In HL-60 cell 
line, exploring the epigenetic events occurring in chromatin, we found the transient instauration of the 
distinctive signature combining the repressive H3Lys27 tri-methylation mark and the activating H3Lys4 
tri-methylation mark (H3K27me3/H3K4me3), indicating a tendency toward a poised chromatin 
conformation. These alterations are lost in time after short-term treatments, while the long-term 
setting, performed using a concentration within the levels of total HQ in peripheral blood of benzene-
exposed workers, showed a gradual increase in H3K4me3. We observed the absence of statistically 
significant variations in DNA methylation and expression levels of LINE-1, despite a decrease in 
protein levels of UHRF1, DNA methyl-transferases and histone methyl-transferases. In conclusion, in 
vitro treatment with low-dose HQ determined the instauration of a reversible poised state of chromatin 
in LINE-1 sequences, suggesting that prolonged exposure could cause persistent epigenetic 
alterations. 
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 In vitro exposure to low-doses HQ can alter the epigenetic signature of AML cell line 
 In vitro treatments with low-doses HQ determine instauration of histone bivalent mark  
 In vitro exposures to low-doses HQ show no significant variation in DNA methylation on LINE-
1 
 Epigenetic modifications after in vitro treatment with HQ are transitory and reversible 
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Abbreviations 
LINE-1 or L1, long interspersed nuclear elements 1; HQ, hydroquinone; AML, acute myeloid 
leukaemia; DNMTs, DNA methyl-transferases; HMTs, histone methyl-transferases. 
 
1. Introduction 
Benzene, a volatile aromatic hydrocarbon, is extensively used in industry even though it is recognized 
as a myelotoxin with leukaemogenic activity, representing a significant occupational risk (Khalade et 
al., 2010): it is also a well-known environmental pollutant, due to its release in the air through cigarette 
smoke and fumes of motor vehicles (Wallace, 1989). Exposure to high concentrations of benzene 
(>100ppm) leads to toxicity in the hemopoietic system, while acute myeloid leukaemia (AML) is the 
major oncogenic disorder associated with chronic exposure, although other forms of leukaemia have 
been reported (Aksoy, 1989; Atkinson, 2009; Khalade et al., 2010; Stenehjem et al., 2015). 
Metabolism of benzene plays a fundamental role in its toxicity (Meek and Klaunig, 2010; Zolghadr et 
al., 2012), and among the different metabolites, hydroquinone (HQ) is one of the most important 
(Snyder and Hedli, 1996), as it can induce several genetic and epigenetic changes (Liu et al., 2012). 
Aberrant patterns of DNA methylation, including loss of imprinting (LOI), gene-specific hyper- or hypo-
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methylation and global hypo-methylation are all common in AML and other tumour types (Lübbert et 
al., 1992; Bollati et al., 2007; Brait and Sidransky, 2011; Hamilton, 2011; Liu et al., 2011), and are 
important for transcriptional repression or activation of cancer-associated genes (Chen et al., 2004; 
Wilson et al., 2007). Nevertheless, the actual mechanism behind the influence of these aberrations on 
tumourigenesis remains unclear. 
DNA methylation of repetitive elements is widely used in research and clinic as an indicator of global 
genomic methylation level, thanks to their high number of copies interspersed in the genome (Yang et 
al., 2004; Sahnane et al., 2015): the best-studied families are the long (LINE-1 or L1) and the short 
(SINEs, in particular Alu) interspersed nuclear elements (Byun et al., 2013). In human studies, 
differences in DNA methylation of L1 and Alu have been consistently demonstrated in response to a 
wide range of environmental exposures, including airborne pollutants (Bollati et al., 2007; Baccarelli et 
al., 2009; Peluso et al., 2012; Seow et al., 2012). LINE-1 DNA hypo-methylation was demonstrated in 
benzene-exposed healthy workers and partially in vitro in HQ treated cells (Bollati et al., 2007; Ji et al., 
2010; Liu et al., 2012). Most of the studies conducted so far have been centred on DNA methylation, 
whereas only a few investigations have analysed the effects of environmental chemicals on histone 
modifications: only recently the relation with benzene exposure was explored (Baccarelli and Bollati, 
2009; Philbrook and Winn, 2015). 
DNA methylation is catalysed by three DNA methyl-transferases (DNMTs) (Portela and Esteller, 
2010): aberrant expression levels of DNMTs induced by environmental carcinogens, accompanied by 
changes in global methylation, have been already observed during leukaemogenesis (Benbrahim-
Tallaa et al., 2007; Ji et al., 2008; Liu et al., 2011). DNA methylation has a role in directing histone 
methylation, and vice-versa, with these two marks supporting each other to establish the chromatin 
environment (Greer et al., 2014; Rose and Klose, 2014): the bridge role between the two epigenetic 
levels is prevalently played by UHRF1 (ubiquitin-like with PHD and ring finger domains 1) (Bronner et 
al., 2013).  
Histone methylation occurs on all basic residues (Fischle et al., 2008) and can happen at multiple 
different residues on the same histone catalysed by several histone methyl-transferases (Greer et al., 
2014). Some histone marks are mutually exclusive: one of the most studied combined methylation is 
the distinctive signature that associates the repressive H3K27 tri-methylation (me3) mark and the 
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activating H3K4me3 mark. This bivalent condition, harboured by many promoters in embryonic stem 
cells and essential during development, was first proposed by Bernstein et (Bernstein et al., 2006) as 
a mechanism to silence developmental genes while keeping them poised for activation, and is lost 
after differentiation. Nowadays it is known to be present also in cancer, where can lead both to 
repression of previously active genes (following loss of H3K4me3), or activation of previously 
repressed sequences/genes associated with cancer progression (following loss of H3K27me3) 
(Chapman-Rothe et al., 2013; Voigt et al., 2013; Hahn et al., 2014).  
The present work aims at addressing the epigenetic changes in response to sub-cytotoxic 
concentrations of HQ, by focusing prevalently on the possible alterations on chromatin and DNA 
methylation. Actually, in vitro demonstration of HQ activity on the epigenetic machinery is difficult to 
achieve due to the nature of the exposure: while acute effects (i.e. apoptosis activation and ROS 
production) are easily evaluable through single high-dose administrations of the agents (Zolghadr et 
al., 2012), and are thus well-studied, long-term exposures at low doses are more difficult to reproduce 
in laboratory. In this study, by setting up a long-term treatment with low-doses of hydroquinone within 
the levels of total HQ found in peripheral blood of benzene-exposed workers, we explore in vitro the 
differences between short and long-term exposure, to evaluate if long-term treatment with low-doses 
of hydroquinone might be sufficient to alter the epigenetic signature, thereby describing a poorly 
explored step in the mechanism of toxicity associated with benzene exposure. 
 
2. Materials and methods 
2.1. Cell line and compounds 
The MPO-positive AML cell line, HL60, was obtained from the American Type Culture Collection 
(ATCC, Rockville, MD, USA) and routinely cultured in suspension at 37°C and 5% CO2 in RPMI 
medium supplemented with 10% foetal bovine serum (Euroclone, MI, IT) and 1% 
penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO, USA). Hydroquinone (HQ, ≥99%) was 
purchased from Sigma-Aldrich, stocked at RT and dissolved in complete medium immediately before 
each treatment. Decitabine (DAC, Sigma-Aldrich) served as a positive control for global DNA 
methylation: stock solutions (50 mM) were prepared in DMSO and stored at -20°C. Working dilutions 
were prepared before use. 
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2.2. Treatment settings 
To analyse cell growth, viability and the epigenetic effects cells were seeded at low density and 
treated 24 hours later following the different settings (detailed treatment schemes are reported in 
Supplementary Figure 1): 
Single treatment: cells were treated once with different concentrations of HQ (1, 5, 15 and 25 μM) 
and harvested 1, 2, 3, 5 and 7 days later; detailed analysis was performed only after treatments with 
HQ 5 and 15 μM. 
Repeated treatment: cells were treated four times every 48 hours with different concentrations of HQ 
(1, 5 and 15 μM) and harvested 2 and 7 days after the fourth treatment; detailed analysis was 
performed only after treatments with HQ 1 and 5 μM. 
Long-term treatment: cells were treated five times a week for five weeks with a single concentration 
of HQ (1 μM). Every seven days cells were counted, reseeded at low density and harvested. The dose 
of 1 M of HQ used in our long-term exposure corresponds to 110 ng/mL HQ, a concentration within 
the range of total HQ found in the blood of workers exposed to airborne benzene (Kerzic et al., 2010); 
that was between 20 and 120 ng/mL, which correspond to free HQ between 2 and 16 ng/mL, for 
airborne benzene exposures ranging from 1 mg/m
3
 (around 0,3 ppm) up to a maximum of 80 mg/m
3
 
(around 25 ppm). 
2.3. Flow cytometry 
Cell were harvested at the different end points, rinsed with PBS and fixed in 70% EtOH at -20 °C for at 
least 20 minutes.  After a further rinse in PBS, DNA was stained with Propidium Iodide in PBS (PI, 
Sigma-Aldrich, final concentration 50 μg/ml) in the presence of RNAse (Sigma-Aldrich, 30 U/ml). 
Samples were analysed at the FACScan flow cytometer (Beckton Dickinson, Franklin Lakes, NJ, USA) 
equipped with a 15 mW, 488 nm and air-cooled argon ion laser. At least 10,000 events were analysed 
for each sample and all data were processed using CellQuest software (Beckton Dickinson). 
Fluorescent emission of PI was collected through a 575 nm band-pass filter and acquired in log mode: 
the percentage of apoptotic cells was determined based on sub-G1 peaks detected in monoparametric 
histograms. 
2.4. SDS page and Western Blot 
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Cell lysates were prepared in RIPA buffer (Sigma-Aldrich) containing protease inhibitor cocktail 
(Roche, Basel, CH). Protein concentration was determined by Qubit method (quant-iT Protein Assay 
kit, Invitrogen, Life Technologies, Carlsbad, CA, USA) and equivalent amounts of total cell lysate (30 
µg) were added with sample buffer 2X (Laemmli, Sigma-Aldrich), separated by 10% acrylamide SDS-
page under denaturing conditions and transferred onto nitrocellulose membrane (Hybond-ECL, GE 
Healthcare, Fairfield, CT, USA). Membranes were incubated overnight with primary antibodies: anti-
DNMT1, (Abcam, Cambridge, UK); anti-DNMT3a (Cell Signaling, Danvers, MA, USA); anti-DNMT3b 
(Active Motif, Carlsbad, CA, USA); anti-UHRF1 (IGBMC, FR); anti-EZH2 (Cell Signaling), anti-
SUV39H1 (GeneTex, Irvine, CA, USA), anti-G9a (Cell Signaling) and anti-GAPDH (Millipore, Merck, 
Darmstatd, DE). After incubation with secondary anti-rabbit/mouse antibody conjugated to horseradish 
peroxidase (Sigma Aldrich), chemioluminescence on membranes was detected by ECL reagents (ECL 
detection reagent, GE Healthcare) and acquired on films (Hyperfilm-ECL, GE Healthcare). 
2.5. DNA bisulfite conversion and pyrosequencing 
Bisulfite modification of genomic DNA (300 ng) was performed with an EpiTect Bisulfite Kit (Qiagen, 
Hilden, DE) according to the manufacturer’s protocol. PCR products were analysed by 
pyrosequencing using PyroGold reagents on a PyroMark Q96 ID system (Qiagen). Pyrogram outputs 
were analysed by the Pyromark ID 1.0 software (Qiagen) to determine the percentage of methylation 
of each of the four CpG sites analysed within the 5’UTR of LINE-1 elements (GenBank ID M80343.1, 
primers in Supplementary Table 1).  
2.6. Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) assays were performed based on a modification of previously 
published methods from our laboratory (Babbio et al., 2012). Briefly, cells were cross-linked by adding 
1% formaldehyde to the culture medium: the cross-linking reaction was quenched by adding 0.125 M 
glycine and collected in PBS. Cell pellets were re-suspended in lysis buffer and sonicated 14 times for 
10 seconds on ice (BRANSON S250 digital sonicator, Branson, Danbury, CT, USA). Sonicated 
chromatin was incubated overnight at 4 °C in dilution buffer with anti-IgG (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), anti-UHRF1 (IGBMC), anti-H3K9me3, anti-H3K9me2, anti-H3K27me3 and 
anti-H3K4me3 (Active Motif). Twenty percent of the total lysate was used for input control. DNA was 
extracted using phenol/chloroform/isoamyl alcohol, precipitated in ethanol and resuspended in H2O. 
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Chromatin immunoprecipitation products were amplified using GoTaq Hot-Start Polymerase 
(Promega, Madison, Wi, USA) and specific primers (Supplementary Table 1) following the 
manufacturer’s protocol. 
2.7. Statistical analysis 
Statistical differences between mean values were determined by using unpaired t-test (since we 
considered differences between NT and each concentration) in GraphPad Prism. Values are 
expressed as mean ± SD of three replicate experiments.  
 
3. Results 
Since the aim of our study was to investigate processes that take place in bone marrow, both catechol 
and hydroquinone were good candidates: however, we chose HL60 cell line as our model, which is 
MPO positive and can thus potentially metabolize HQ to benzoquinone, to possibly analyze the 
combined effects of both compounds. Exploring in vitro the differences between short and long-term 
exposure to HQ, in the effort to investigate if low-doses might be sufficient to alter the epigenetic 
signature, we developed three treatment settings: detailed explanation of the settings is reported in 
material and methods and Supplementary Figure 1. We evaluated cell viability to chose sub-cytotoxic 
concentrations in each setting: HQ concentrations of 1, 5, and 15 µM were selected as representative 
of low dose HQ. In particular, the concentration of 1μM (110 ng/mL) used in the long-term treatment is 
within the total HQ levels found in workers exposed up to 80 mg/m
3
 of airborne benzene (Kerzic et al., 
2010). The selected doses were used to assess the alterations in the epigenetic components, in DNA 
methylation levels and in chromatin modifications. 
3.1. Effects on HL60 viability induced by different treatments with HQ 
As a first step, we analysed the cytotoxic effect of HQ on HL60 cell line in the different settings, 
starting from literature data available exclusively for a single exposure (Terasaka et al., 2005; Ji et al., 
2010; Liu et al., 2012). In response to a single administration, with the exception of the highest 
concentration (25 μM), we could observe no significant difference in cytotoxicity shortly after the 
treatment (1d-3d) between concentrations, while at longer times (5d-7d) 15 μM slightly reduced cell 
proliferation (Figure 1A). Increasing the number of treatments up to four (excluding 25 μM), we 
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detected high toxicity at 15 μM and a slight reduction in cell growth at 5 μM: 1 μM didn’t affect cell 
proliferation (Figure 1B). In order to study HQ effects following prolonged exposure, we provided daily 
administrations of the lowest concentration (1 μM) for multiple weeks. We did not observe significant 
effects on cell growth for the first three weeks: a reduction in the cell number was observed at the 
fourth week and became massive the fifth week. The reduced growth affected only the treated cells, 
while non-treated cells showed no visible effect compared with the previous weeks (Figure 1C), 
underlying that cell toxicity was due to the compound, and not to prolonged cultivation (see 
Supplementary Figure 1). As in our experimental setting HL60 cells undergo a reduction in cell growth 
after 8 week of cultivation, possibly due to the accumulation of stress factors, it might be that low-dose 
HQ contributes to the stress load that leads the cells to arrest/undergo senescence/die in a shorter 
time with respect to controls. 
Following these observations, we concluded that even a very low concentration of HQ such as 1 μM 
(within total HQ levels found in peripheral blood of benzene-exposed workers), could not be 
administered in vitro for long periods in the selected cell line due to its toxic effect. Analyses of the 
epigenetic alterations, therefore, were performed only on the doses and times where the effect on 
viability was not significant (single, 5 and 15 μM; repeated, 1 and 5 μM; long-term, 1 μM up to four 
weeks; the fifth week was not analysed).  
We evaluated the effect of the selected sub-cytotoxic doses on cell cycle progression and apoptosis: 
flow cytometry analysis evidenced that single and repeated exposures are not able to alter the 
percentage of cycling cells and of apoptotic cells (Figures 1D and 1E). Long-term treatment showed a 
slight reduction in G0/G1 starting from the second week of treatment and a slight increase of the 
apoptotic cells in the fourth week of treatment only (Figure 1F). This feeble increase, however, does 
not seem to be sufficient to explain the decline in growth observed a week later: further analyses, not 
object of this study, are necessary. 
3.2. Variations in DNMTs, UHRF1 and HMTs levels induced by different treatments with 
HQ 
We explored the variations occurring at protein levels in the components necessary for the 
maintenance of DNA and histone methylation (UHRF1, DNMTs and some HMTs) following exposure 
to HQ. After a single treatment (5 and 15 μM), we could detect an effect prevalently 5 days after the 
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exposure: a visible reduction of variable entity, more pronounced in UHRF1 and DNMT1, is visible. 
These differences were still partially present two days later (Figure 2A). When evaluating the effect of 
lower doses (1 and 5 μM) after a repeated exposure, we observed a dose dependent decrease in 
protein levels, especially of DNMT1 and G9a, 2 days after the 4
th
 treatment (Figure 2B): five days 
later, independently from the used concentration, protein levels were comparable to non-treated 
samples, displaying the ability of HL60 to recover to basal level in the absence of HQ (Figure 2B). If 
we look at the effect of a prolonged exposure to a low dose of HQ (1 μM), it becomes clear that this 
benzene metabolite is indeed able to down-regulate the epigenetic components analysed (Figure 2C): 
the reduction was visible starting from the second week of treatment, and was maintained in the 
following weeks.  
Concurrently we analysed the effect of HQ on transcriptional levels (Supplementary Figure 2), 
confirming the previously observed tendency towards a decrease in DNMTs transcription reported in 
literature (Liu et al., 2012) and showing variable alterations of UHRF1 and the HMTs investigated.  
We concluded that repeated administrations of very-low doses of HQ, such as 1 μM, are able to 
maintain down-regulation of important epigenetic modifiers.  
3.3. Effect of the exposure to HQ on global methylation 
Given the variations observed in UHRF1 and DNMTs proteins, as well as the evidences in literature 
(Bollati et al., 2007; Ji et al., 2010; Liu et al., 2012), we investigated DNA methylation status on the 
5’UTR region of LINE-1, vastly utilized in research and clinic for the evaluation of methylation levels 
(Sahnane et al., 2015), after exposure to HQ. Analysing 5 and 7 days following the single treatment 
we could not detect statistically significant variations: we could observe only a slight tendency towards 
a dose dependent reduction 5 days after the exposure, reduction that was lost in the samples 
harvested two days later (Figure 3A). As Figure 3B shows, the effects of the repeated treatment on 
LINE-1 methylation 2 days after the 4
th
 treatment are less linear, with a slight decrease only at the 
highest dose, while 5 days later the levels of methylation were again back to basal. Completing the 
methylation analysis on the long-term treatment (Figure 3C), we could not observe significant 
variations in any of the time-points analysed. In correspondence to the absence of alterations on DNA 
methylation we could observe no significant variations in LINE-1 5-UTR transcriptional levels (Figure 
3D, E and F) in any of the treatment settings. 
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In conclusion, the treatment settings used in this work were not able to significantly alter DNA 
methylation and transcription of LINE-1, even when the exposure was prolonged up to four weeks. 
3.4. Effect of the exposure to HQ on chromatin accessibility at LINE-1 loci 
Focusing our attention on chromatin, given the variations observed in HMTs proteins, we performed 
ChIP experiments on LINE-1 5’UTR (the same region evaluated by pyrosequencing and qPCR, 
containing the promoter) aimed at evaluating covalent histone modifications and UHRF1 binding. In 
basal condition, we could observe the presence of repressive marks, such as UHRF1 binding and 
H3K27 tri-methylation. Data on H3K9 showed the prevalence of bi-methylation vs. tri-methylation: this 
could be due to the hypothesis that the sequences analysed by PCR are in fact the more conserved 
intronic LINE-1, where bi-methylation is prevalent, but also from the fact that HL60 possess very low 
levels of SUV39H1 (the HMT deputed to H3K9 tri-methylation). H3K4me3 was generally absent, as 
expected in transcriptionally-repressed and hyper-methylated sequences (Figure 4A).  
Following exposure to HQ, Figure 4B shows the appearance of H3K4 tri-methylation, coupled with 
retention of H3K27 tri-methylation, 5 days after single treatment, meaning the instauration of a poised 
chromatin conformation. Variations in UHRF1 binding and of H3K9me2 were less reproducible and 
were not analysed. Two days later, however, the effect on chromatin was lost, with the restoration of 
the basal condition (appreciable both by PCR products visualization and densitometric analysis, 
Figure 4B). Similarly to what observed for the single treatment, an increase in H3K4me3, again 
coupled with preservation of H3K27me3, was visible 2 days after the 4
th
 treatment, but resulted lost 5 
days later (Figure 4C). Finally, analysing the variations in chromatin markers after long-term treatment, 
we could observe a progressive effect from week 1 through week 4 with a gradual increase in the 
levels of H3K4me3 (Figure 4D). Levels of H3K27me3 were stable at all time-points. These alterations, 
however, as shown above were not sufficient to determine significant variations in LINE-1 5-UTR 
transcriptional levels, probably due to the maintenance of repressive markers (H3K27me3 and DNA 
methylation, Figure 3). 
In conclusion, this first analysis on chromatin modifications of LINE-1 sequences showed that even a 
single exposure to HQ is enough to perturb the structure of non-active DNA portion of the genome. 
However these changes, in the case of short-term treatments, are lost in time, suggesting the ability of 
HL60 to revert to the original conformation in the absence of HQ and thus the necessity of a prolonged 
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exposure for the persistence of these alterations: we could not evaluate at long-term the persistence 
of this alterations in the absence of HQ due to the instauration of cytotoxicity. 
 
4. Discussion 
In the last few years, several investigations have examined the relationship between exposure to 
environmental chemicals and epigenetics, and have identified numerous agents able to modify 
epigenetic marks. Most of the studies conducted so far have been centred on DNA methylation, 
whereas only recently a few have focused on the effects on histone modifications (Bollati et al., 2007; 
Wilson et al., 2007; Baccarelli and Bollati, 2009). Benzene and its metabolites are among the most 
studied, due to their association with diverse hematopoietic malfunction as well as leukemogenesis: 
global DNA hypo-methylation, accompanied by gene-specific hyper-methylation, was demonstrated in 
benzene-exposed healthy workers (Bollati et al., 2007). However, in vitro demonstration of benzene 
activity on the epigenetic machinery is complicated by the nature of the type of exposure behind these 
changes: while studies on benzene and its metabolites on acute effects (i.e. apoptosis activation and 
ROS production) are easily achievable using single high-dose administrations of the agents (Zolghadr 
et al., 2012), chronic exposures at very low doses, comparable to the ones reached in occupational 
exposure, are more difficult to reproduce in laboratory. 
Epidemiological studies have shown that airborne benzene concentrations ≤1ppm are able to give 
hematotoxicity in workers exposed for long periods (Lan et al., 2004). Mild reduction of DNA 
methylation (-2,33%) at LINE-1 sequences occurs in workers exposed to ≤1ppm of airborne benzene 
for many hours per day and for at least one year (Fustinoni et al., 2005). In the present work, we 
extended these studies in HL60 exposed cells, focusing firstly on finding sub-cytotoxic concentrations 
and setting different types of treatments in the effort to move towards a long-term treatment scheme 
that could somehow recall exposures that can be experienced in working environments. The HQ 
concentration we used (1 µM) corresponds to 110 ng/mL, a level very similar to the highest amount of 
total HQ (between 20 and 120 ng/mL, corresponding to 2-16 ng/mL of free HQ) found in the blood of 
workers of a rubber product manufacturing and finishing facility located near Shanghai, China (Kerzic 
et al., 2010), exposed to airborne benzene levels ranging from 1 mg/m
3
 (around 0,3 ppm) up to a 
maximum of 80 mg/m
3
 (around 25 ppm). Interestingly, the highest blood levels of total HQ were 
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observed even at very low levels of air benzene exposure (≤1ppm), levels that have been shown to 
cause hematotoxicity (Lan et al., 2004). Moreover, when the ratio of bound to unbound metabolites 
were compared in subsets of exposed workers, the increase in blood metabolite concentration was 
nearly all due to an increase in the protein-bound molecule. These results suggest that it is very 
difficult to define a tight correlation between the level of benzene exposure and the concentration of 
HQ, especially the free form, in the blood. Considering that HQ has a half life of at least 20hr (IPCS, 
INCHEM, SIDS 2002), that the molecule undergoes rapid redox reactions and that 10% FBS present 
in the medium contains many HQ-binding proteins, the amount of free HQ may vary considerably 
during the experiments, making it difficult to accurately measure the final concentration of free HQ. 
Altogether, the 110 ng/mL HQ used for the long-term experiments is close to the maximum total levels 
detected in the blood of the workers (120 ng/mL), in the effort to mimic in vitro the conditions of a 
strong occupational exposure, although we could not define the exact working concentration range of 
free HQ.   
We focused our attention on alteration in the epigenetic machinery occurring in each setting at the 
times and doses where cell viability was retained and variations in cell cycle/apoptosis were absent or 
not significant, to avoid non-specific effects, analysing both histone modifications and DNA 
methylation. Aberrant expression of DNMTs, accompanied by hyper-methylation of tumour suppressor 
genes and hypo-methylation of unique genes or repetitive sequences, are the main types of aberration 
in the DNA methylation machinery occurring in AML and other cancer types (Brait and Sidransky, 
2011; Hamilton, 2011).  
Given the variations observed in our study in HMTs proteins (as well as UHRF1), we primarily focused 
our attention on chromatin, performing a ChIP experiment on LINE-1 5’UTR (the region containing the 
promoter sequence of this retrotransposable element): our aim was to evaluate for the first time some 
of the histone modification in these regions, in particular H3K9me3, H3K9me2, H3K27me3 and 
H3K4me3, as well as UHRF1 binding. We applied stringent PCR condition in order to prevalently 
evaluate conserved sequences (present in intronic regions, where the interspersed LINE-1 are better 
preserved) that can give origin to chimeric transcript or to the production of proteins responsible for the 
insertional activity of LINE-1 sequences (Slotkin and Martienssen, 2007).  
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At first analysis, in treated cells we observed the instauration of various degrees of H3K4 tri-
methylation, absent in basal condition, which evidenced the tendency toward a poised chromatin 
conformation typical of embryonic cells and normally lost during development. The persistence of 
H3K27me3, coupled with H3K4me3 (two histone marks associated with opposite transcriptional status 
and actually widely recognized as a bivalent mark) clearly shows the transition in these sequences 
towards a more permissive conformation following exposure to HQ, as illustrated in the hypothetical 
model in Figure 5. In this figure we represented what we experimentally observed (5A and 5B) and the 
two hypothetical fates: if the exposure is removed (Fig 5C, left) we could observe restoration of the 
initial condition, with loss of tri-methylation on K4 and persistence of K27me3; if the exposure 
becomes chronic (Fig 5C, right) it might end up with the loss of repressive marks (K27me3) and 
activation of transcription in the presence of K4me3. The plasticity of this fundamental chromatin 
bivalent mark (H3K27me3/H3K4me3), firstly described in embryonic cells, appears to play a role also 
in poising non-active genes for aberrant transcription in cancer (Bernstein et al., 2006; Voigt et al., 
2013). Several studies actually suggest that loss of this bivalent chromatin mark at promoters is 
accompanied by gene activation (when H3K27me3 is lost) or gene repression (when H3K4me3 is lost) 
during development, and this event is likely to be a critical step also in cancer pathogenesis, 
responsible for the activation of crucial genes leading to progression and invasiveness, as 
demonstrated in colon and ovarian cancer (Chapman-Rothe et al., 2013; Hahn et al., 2014). 
These variations, however, seems not persistent in time: analysis at longer intervals after the 
exposure to single and repeated treatments showed a recovery in LINE-1 chromatin modifications, 
meaning the ability of HL60 to revert to the original chromatin configuration in the absence of HQ 
stimulus. This reversibility could be interpreted as a cellular mechanism of defence against 
environmental insults that can produce permanent modifications in chromatin, ultimately leading to 
alteration in the transcriptional levels of targeted genes/sequences. In case of environmental chronic 
exposure, in fact, the persistence of the agent might lead to the fixation of the alteration at later t imes: 
permanent gain of H3K4me3, possibly followed by loss of H3K27me3, could determine the 
reactivation of the studied sequences, as previously demonstrated for gene promoters in other cancer 
types (Hahn et al., 2014).  
However, even long-term administration in these in vitro conditions were not enough to stabilize these 
alterations, as the concentration used determined toxicity before we could assess if these 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 16 
modifications could be fixed in time. We speculated that the responses we obtained in ChIP 
experiments are hydroquinone specific and not only 'simply' stress related, as the epigenetic effects 
were visible since the first week of treatment, and both with single and repeated treatments. It is 
known that HQ treatment produces cellular stress, contributing to the general stress load that leads to 
cytotoxicity and alteration in the cellular life span even at doses as low as 1 μM. Further experiments 
will be needed to investigate better the nature of the 5th week collapse, and to understand which 
phenotype is generated (cell arrest/senescence/death or other) and which mechanism is responsible 
for it. 
Given the alterations observed in chromatin, as well as in UHRF1 and DNMTs proteins and the 
evidences in literature (Bollati et al., 2007; Ji et al., 2010; Liu et al., 2012), we investigated the DNA 
methylation status on the same 5’UTR region of LINE-1 by pyrosequencing. Actually, the decrease in 
global methylation is largely studied at heavily methylated elements, such as satellite repeats (i.e. 
Sat2) and retrotransposons (i.e. LINE-1) (Yang et al., 2004; Sahnane et al., 2015). We could not 
detect a significant difference in all the settings, but a slight reduction in methylation was visible: these 
results indicate that global DNA hypo-methylation may only partially result from DNMTs inhibition 
induced by HQ exposure. Overall, we could not reproduce in vitro the alteration in LINE-1 methylation 
observed in epidemiologic studies (Bollati et al., 2007), even after a long-term exposure to HQ: in fact, 
even prolonging the exposure was not sufficient to have statistically significant variations, clearly 
underlying the difficulties of a similar study in an in vitro setting.  
The persistence of H3K27me3 observed by ChIP could be considered responsible for the absence of 
significant alteration in DNA methylation, even in the presence of H3K4me3, as well as for the 
absence of meaningful variations of LINE-1 transcriptional levels. As already stated, in case of 
environmental exposure, the persistence of the insult, more than the concentration of the pollutant, 
might determine the alteration of repressive and activating modifications, ultimately leading to DNA 
hypo-methylation and variation also in transcription, since histone and DNA modifications are strictly 
correlated and both determine the effect on promoter activation or repression. 
Future investigations are thus needed to determine whether long-term exposed subjects develop 
stable epigenetic alterations on chromatin that can precede alteration in DNA methylation, and, in turn, 
whether such alterations could increase the risk of cancer after exposure to benzene and its 
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metabolites. Given the technical difficulties in setting in vitro experiments reproducing occupational 
and environmental exposures, epidemiological and in vivo studies are probably the best alternatives. 
Additional studies are indeed required to investigate the mechanism by which benzene and its 
metabolites produce the alterations observed for the first time in this work, as well as the role of these 
modifications in AML development. 
 
5. Conclusions 
Exploring the epigenetic events occurring in chromatin, after in vitro treatment with concentrations of 
HQ representative of the levels produced by occupational exposures to airborne benzene, not able to 
alter cellular growth, we found the transient instauration in LINE-1 sequences of the combined 
signature H3K27me/H3K4me3, indicating the instauration of a poised chromatin conformation 
normally visible during development. The loss of these alterations after short-term treatments and the 
gradual increase in H3K4me3 observed after long-term treatment suggest the necessity of a 
prolonged exposure for the persistence of these epigenetic changes. This might explain the absence 
of statistically significant variations in DNA methylation in all settings, differently from what observed in 
epidemiologic studies, as well as in LINE-1 expression, even in the presence of decreased protein 
levels of UHRF1, DNMTs and HMTs. 
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Figure legends 
Fig. 1. Survival curve and flow cytometry analysis of HL60 cells treated with HQ.  (A, B, C) Cell 
counting was performed to evaluate the effect of HQ on cell growth: concentration of 25 μM in the 
single treatment (A) and of 15 μM in the repeated treatment (B) resulted highly toxic and were thus 
excluded in the following experiments, while in the long-term treatment even a very low concentration 
(1 μM) resulted toxic after four weeks (C). (D, E, F) The effect on cell cycle distribution and apoptosis 
levels was evaluated through flow cytometry: at the selected concentrations no significant alteration in 
the percentage of cycling and apoptotic cells was observed, with the exception of the long-term 
treatment, where we could detect a slight increase in apoptosis after the 4
th
 week of treatment and a 
decrease in G0/G1 cells starting from the 2
nd
 week of exposure. All results are shown as mean + SD 
of four independent biological replicates. * P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.0001. 
Fig. 2. Evaluation of factors involved in epigenetic modifications after different treatments with HQ. (A, 
B, C) DNMTs, UHRF1 and HMTs protein levels were evaluated by Western Blot (single exposure in A, 
repeated in B and long-term in C). GAPDH levels were evaluated as internal control. Western Blot 
panels (on the left) are representative of the average variations observed in three independent 
biological replicates: DNMT3b is not shown because it was not detectable in any condition. The 
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densitometry graphs (on the right) show the variations at the different times or concentrations, each 
compared to basal levels (NT): the results are shown as mean + SD of two independent biological 
replicates. * P ≤ 0.05. 
Fig. 3. Evaluation of DNA methylation (A, B, C) and transcription (D, E, F) of LINE-1 after the different 
treatments with HQ. Four different cytosines in the 5’UTR region of LINE-1 were evaluated through 
Pyrosequencing analysis. Results are shown as mean + SD of the average of the four cytosines of 
three independent biological replicates. Transcriptional levels were evaluated through qPCR on the 
same region, harboring the promoter and transcribed: variation in expression are compared to basal 
levels (NT). The results are shown as mean + SD of three independent biological replicates. (A, D) 
Single treatment. (B, E) Repeated treatment. (C, F) Long-term treatment.  
Fig. 4. Evaluation of histone modifications on chromatin after treatment with HQ. (A) Levels of 
H3K9me3, H3K9me2, H3K27me3 and H3K4me3, as well as UHRF1 binding, were evaluated in the 
5’UTR region of LINE-1 through chromatin immunoprecipitation in basal conditions. (B, C, D) Analysis 
at the different end-points of the three treatment settings (single exposure in B, repeated in C and 
long-term in D) focused principally on H3K27me3 and H3K4me3. The chromatin status was evaluated 
also on a constitutively active gene (GAPDH). PCR panels are representative of the average 
variations observed; densitometry analysis of LINE-1 are shown as mean + SD of three independent 
biological replicates and are normalized versus IgG and Input. * P ≤ 0.05. 
Fig. 5. Hypothetical model of chromatin alteration on LINE-1 5’UTR after treatment with HQ. (A) In 
basal condition, we observed the presence of repressive marks, such as H3K27 tri-methylation (as 
well as UHRF1 and H3K9me2, not reported in figure); H3K4me3 was generally absent, as expected in 
transcriptionally-repressed sequences. (B) After treatment with HQ we observed the appearance of 
H3K4 tri-methylation, coupled with retention of H3K27 tri-methylation, indicating a poised chromatin 
conformation. These variations, however, were not stable in time and were not sufficient to determine 
significant variations in LINE-1 5-UTR transcriptional levels, probably due to the maintenance of 
repressive markers (like H3K27me3 and methylation). (C) Following chronic exposure to HQ, LINE-1 
sequence could hypothetically lose the repressive marks and activate transcription, while in the 
absence of the pollutant the original conformation of the chromatin could be restored. 
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